[FG] Meier Christian

Meier, Christian et al. (2023) ‘Biochemical Markers of Bone Fragility in Patients With Diabetes’, The Journal of Clinical Endocrinology & Metabolism, 108(10), pp. e923–e936. Available at: https://doi.org/10.1210/clinem/dgad255.

Monnerat, Sophie et al. (2023) ‘An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD’, The Journal of Clinical Endocrinology & Metabolism, 108(10), pp. e1027–e1033. Available at: https://doi.org/10.1210/clinem/dgad238.

Ferrari, Serge and Meier, Christian (2023) ‘Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 153(4). Available at: https://doi.org/10.57187/smw.2023.40075.

Jung, Ruedi et al. (2023) ‘Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)’, International Journal of Cancer, 152(2), pp. 162–171. Available at: https://doi.org/10.1002/ijc.34234.

R Charlier SH et al. (2022) ‘Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study’, Cardiovascular Diabetology, 21(1), p. 2. Available at: https://doi.org/10.1186/s12933-021-01432-1.

Vavanikunnel, Janina et al. (2022) ‘Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH’, Calcified Tissue International, 111(6), pp. 587–596. Available at: https://doi.org/10.1007/s00223-022-01022-7.

Bischof E et al. (2022) ‘Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience’, Bone Reports, 16, p. 101160. Available at: https://doi.org/10.1016/j.bonr.2021.101160.

Sewing L et al. (2022) ‘Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes’, Journal of Bone and Mineral Research, 37(5), pp. 837–847. Available at: https://doi.org/10.1002/jbmr.4517.

Jehle‐kunz, Sigrid et al. (2022) ‘Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey’, Healthcare (Switzerland), 10(2). Available at: https://doi.org/10.3390/healthcare10020295.

Paccou J. et al. (2022) ‘Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)’, Bone, 154. Available at: https://doi.org/10.1016/j.bone.2021.116236.

Potasso L et al. (2022) ‘Effect of hyponatremia normalization on osteoblast function in patients with SIAD’, European Journal of Endocrinology, 186(1), pp. 1–8. Available at: https://doi.org/10.1530/EJE-21-0604.

Vavanikunnel, J. et al. (2022) ‘Determinants of low bone turnover in type 2 diabetes-the role of PTH’, Calcif Tissue Int, 111(6), pp. 587–596. Available at: https://doi.org/10.1007/s00223-022-01022-7.

Charlier, Sarah et al. (2021) ‘Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study’, Journal of Clinical Endocrinology and Metabolism, 106(2), pp. 554–566. Available at: https://doi.org/10.1210/clinem/dgaa796.

Maushart, Claudia Irene et al. (2021) ‘Free Thyroxine Levels are Associated with Cold Induced Thermogenesis in Healthy Euthyroid Individuals’, Frontiers in Endocrinology, 12, p. 666595. Available at: https://doi.org/10.3389/fendo.2021.666595.

Tsourdi E et al. (2021) ‘Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS’, Journal of Clinical Endocrinology and Metabolism, 106(1), pp. 264–281. Available at: https://doi.org/10.1210/clinem/dgaa756.

Sewing, Lilian et al. (2020) ‘Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes’, Journal of Bone and Mineral Research, 37(5), pp. 837–847. Available at: https://doi.org/10.1002/jbmr.4517.

Zürcher SJ et al. (2020) ‘High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit’, International Journal of Cancer, 147(7), pp. 1845–1854. Available at: https://doi.org/10.1002/ijc.32963.

Ferrari S et al. (2020) ‘2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 150(3940), p. w20352. Available at: https://doi.org/10.4414/SMW.2020.20352.

Pepe J. et al. (2020) ‘Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF’, Journal of Clinical Endocrinology and Metabolism, 105(8), pp. 2487–2506. Available at: https://doi.org/10.1210/clinem/dgaa306.

Kumps C et al. (2020) ‘The connective tissue disorder associated with recessive variants in the SLC39A13 zinc transporter gene (Spondylo-dysplastic ehlers–danlos syndrome type 3): Insights from four novel patients and follow-up on two original cases’, Genes, 11(4). Available at: https://doi.org/10.3390/genes11040420.

Müller F et al. (2020) ‘Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee’, Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), pp. 408–417. Available at: https://doi.org/10.1007/s00167-019-05598-w.

Anastasilakis AD et al. (2019) ‘Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society’, Bone, 127, pp. 401–418. Available at: https://doi.org/10.1016/j.bone.2019.07.006.

Biver E, Calmy A and Meier C (2019) ‘Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf’, 30(8). Available at: https://doi.org/10.1007/s00198-019-05025-3.

Vahidnezhad H et al. (2019) ‘Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency.’, Matrix biology : journal of the International Society for Matrix Biology, 81, pp. 91–106. Available at: https://doi.org/10.1016/j.matbio.2018.11.006.

Biver E et al. (2019) ‘Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis’, Osteoporosis International, 30(5), pp. 1125–1135. Available at: https://doi.org/10.1007/s00198-018-4794-0.

Struja T et al. (2019) ‘Comparison of Five TSH-receptor antibody assays in Graves” disease: Results from an observational pilot study’, BMC Endocrine Disorders, 19(1), p. 38. Available at: https://doi.org/10.1186/s12902-019-0363-6.

Ebrahimi, Fahim et al. (2019) ‘Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials’, European Respiratory Journal, 53(2), p. 10.1183/13993003.00973–2018. Available at: https://doi.org/10.1183/13993003.00973-2018.

Struja T et al. (2019) ‘Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study’, Hormone and Metabolic Research, 51(4), pp. 256–260. Available at: https://doi.org/10.1055/a-0850-9691.

Vavanikunnel, Janina et al. (2019) ‘Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study’, The Journal of Clinical Endocrinology and Metabolism, 104(5), pp. 1645–1654. Available at: https://doi.org/10.1210/jc.2018-01879.

Ferrari SL et al. (2018) ‘Diagnosis and management of bone fragility in diabetes: an emerging challenge.’, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(12), pp. 2585–2596. Available at: https://doi.org/10.1007/s00198-018-4650-2.

Refardt, Julie et al. (2018) ‘Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy.’, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 16.04.2018, 34(10), pp. 833–836. Available at: https://doi.org/10.1080/09513590.2018.1462314.

Giunta C et al. (2018) ‘A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.’, Genetics in medicine : official journal of the American College of Medical Genetics, 20(1), pp. 42–54. Available at: https://doi.org/10.1038/gim.2017.70.

Struja T et al. (2018) ‘Metabolomics for Prediction of Relapse in Graves” Disease: Observational Pilot Study.’, Frontiers in endocrinology, 9, p. 623. Available at: https://doi.org/10.3389/fendo.2018.00623.

Rueegg CS et al. (2017) ‘A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].’, BMC cancer. 05.12.2017, 17(1), p. 822. Available at: https://doi.org/10.1186/s12885-017-3801-8.

Kanis JA et al. (2017) ‘Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.’, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 28(11), pp. 3285–3286. Available at: https://doi.org/10.1007/s00198-017-4161-6.

Struja T et al. (2017) ‘Is Graves” disease a primary immunodeficiency? New immunological perspectives on an endocrine disease’, BMC Medicine, 15(1), p. 174. Available at: https://doi.org/10.1186/s12916-017-0939-9.

Meier C et al. (2017) ‘Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)’, Swiss Medical Weekly. 16.08.2017, 147, p. w14484. Available at: https://doi.org/10.4414/smw.2017.14484.

Kanis JA et al. (2017) ‘Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.’, pp. 2023–2034. Available at: https://doi.org/10.1007/s00198-017-4009-0.

Gotthardt, Frank et al. (2017) ‘Bone mineral density and its determinants in men with opioid dependence’, Journal of bone and mineral metabolism, 35(1), pp. 99–107. Available at: https://doi.org/10.1007/s00774-015-0732-9.

Struja, Tristan et al. (2017) ‘External validation of the GREAT score to predict relapse risk in Graves” disease: results from a multicenter, retrospective study with 741 patients’, European Journal of Endocrinology, 176(4), pp. 413–419. Available at: https://doi.org/10.1530/eje-16-0986.

Struja, Tristan Mirko et al. (2017) ‘Personalised immunomodulating treatments for Graves” disease: fact or fiction?’, Swiss Medical Weekly, 147, p. w14476. Available at: https://doi.org/10.4414/smw.2017.14476.

Egger A, Kraenzlin ME and Meier C (2016) ‘Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health’, Current Osteoporosis Reports, 14(6), pp. 345–350. Available at: https://doi.org/10.1007/s11914-016-0337-9.

Oranges CM, Meier C and Schaefer DJ (2016) ‘Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients’, 138(3). Available at: https://doi.org/10.1097/PRS.0000000000002506.

Spoendlin, Julia et al. (2016) ‘New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study’, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WOS.SCI, 25, pp. 563–563.

Egger, A., Kraenzlin, M. and Meier, C. (2016) ‘Osteoporosis and type 2 diabetes’, DIABETOLOGE. WOS.SCI, 12, pp. 254–260. Available at: https://doi.org/10.1007/s11428-016-0098-1.

Trombetti A et al. (2016) ‘Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms’, Journal of Endocrinological Investigation, 39(5), pp. 567–576. Available at: https://doi.org/10.1007/s40618-015-0423-3.

Meier C et al. (2016) ‘Effects of diabetes drugs on the skeleton’, Bone, 82, pp. 93–100. Available at: https://doi.org/10.1016/j.bone.2015.04.026.

Spoendlin, Julia et al. (2016) ‘The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study’, Drug Safety, 39(12), pp. 1229–1237. Available at: https://doi.org/10.1007/s40264-016-0462-5.

Spoendlin, Julia et al. (2016) ‘Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study’, Journal of Diabetes and its Complications, 30(5), pp. 903–9. Available at: https://doi.org/10.1016/j.jdiacomp.2016.02.017.

Suhm N et al. (2016) ‘[FLS - three letters alter secondary fracture prevention].’, Der Unfallchirurg, 119(1), pp. 12–7. Available at: https://doi.org/10.1007/s00113-015-0122-8.

Theiler, R. et al. (2016) ‘Capture the fracture by SMS’, OSTEOLOGIE. WOS.ESCI, 25, pp. 283–286.

Lindert U et al. (2015) ‘Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta.’, Orphanet journal of rare diseases, 10, p. 104. Available at: https://doi.org/10.1186/s13023-015-0315-9.

Meier C (2015) ‘Benefits and place of calcimimetics in the management of primary hyperparathyroidism’, Annales d’Endocrinologie, 76(2), pp. 163–164. Available at: https://doi.org/10.1016/j.ando.2015.03.019.

Spoendlin, Julia et al. (2015) ‘Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study’, Annals of medicine, 47(6), pp. 492–8. Available at: https://doi.org/10.3109/07853890.2015.1074272.

Meier, Christian et al. (2014) ‘The role of teriparatide in sequential and combination therapy of osteoporosis’, Swiss Medical Weekly. WOS.SCI, 144. Available at: https://doi.org/10.4414/smw.2014.13952.

Kraenzlin M and Meier C (2014) ‘Sexualhormone und Knochen.’, Therapeutische Umschau. Revue therapeutique, 71(4), pp. 209–19. Available at: https://doi.org/10.1024/0040-5930/a000504.

Stute P et al. (2014) ‘Gynaecologists” awareness of bone healthcare in Switzerland’, Swiss Medical Weekly. 26.02.2014, 144, p. w13931. Available at: https://doi.org/10.4414/smw.2014.13931.

Kreutle, V. et al. (2014) ‘Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature’, Swiss Medical Weekly, 144, p. w13979. Available at: https://doi.org/10.4414/smw.2014.13979.

Meier, C et al. (2014) ‘Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial’, Osteoporosis international, 25(1), pp. 359–66. Available at: https://doi.org/10.1007/s00198-013-2581-5.

Nigro N, Christ-Crain M. and Meier C (2014) ‘Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken’, Therapeutische Umschau, 71(4), pp. 229–237. Available at: https://doi.org/10.1024/0040-5930/a000506.

De Geyter,Christian and Birkhäuser,Martin (2014) ‘[In Process Citation]’, Ther Umsch, 71(5), pp. 239–43.

Henzen C, Kraenzlin M and Meier C (2013) ‘[Laboratory investigation of endocrine function - interpretation of results and pitfalls].’, Therapeutische Umschau. Revue therapeutique, 70(8), pp. 481–9. Available at: https://doi.org/10.1024/0040-5930/a000435.

Sieber P et al. (2013) ‘Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice’, Clinical Drug Investigation, 33(2), pp. 117–122. Available at: https://doi.org/10.1007/s40261-012-0041-1.

Meyer, Ursina et al. (2013) ‘3-year follow-up results of bone mineral content and density after a school-based physical activity randomized intervention trial’, Bone, 55(1), pp. 16–22. Available at: https://doi.org/10.1016/j.bone.2013.03.005.

Starke A et al. (2012) ‘Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality’, Clinical Journal of the American Society of Nephrology. 05.07.2012, 7(9), pp. 1461–1472. Available at: https://doi.org/10.2215/CJN.01100112.

Meier C and Kraenzlin ME (2012) ‘[Osteoporosis: evaluation, diagnosis and monitoring].’, Therapeutische Umschau. Revue therapeutique, 69(3), pp. 145–52. Available at: https://doi.org/10.1024/0040-5930/a000267.

Bodmer, Michael et al. (2012) ‘Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis’, The American journal of gastroenterology, 107(4), pp. 620–626. Available at: https://doi.org/10.1038/ajg.2011.483.

Bodmer, Michael et al. (2012) ‘Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis’, Cancer epidemiology biomarkers & prevention, 21(2), pp. 280–286. Available at: https://doi.org/10.1158/1055-9965.epi-11-0992-t.

Rizzoli R et al. (2011) ‘[Osteoporosis in Switzerland in 2011: change since 2008].’, 7(299).

Suter-Widmer I, Kraenzlin ME and Meier C (2011) ‘[Primary hyperparathyroidism].’, Therapeutische Umschau. Revue therapeutique, 68(6), pp. 321–6. Available at: https://doi.org/10.1024/0040-5930/a000172.

Lamy O and Kraenzlin M (2011) ‘[Osteoporosis: evaluation and fracture risk].’, Revue medicale suisse, 7(294), pp. 1018–9.

Bodmer, Michael et al. (2011) ‘Use of metformin and the risk of ovarian cancer: a case-control analysis’, Gynecologic oncology, 123(2), pp. 200–204. Available at: https://doi.org/10.1016/j.ygyno.2011.06.038.

Dürsteler-MacFarland, Kenneth M et al. (2011) ‘Patients on injectable diacetylmorphine maintenance have low bone mass’, Drug and alcohol review, 30(6), pp. 577–82. Available at: https://doi.org/10.1111/j.1465-3362.2010.00242.x.

Kraenzlin, Marius E and Meier, Christian (2011) ‘Parathyroid hormone analogues in the treatment of osteoporosis’, Nature reviews. Endocrinology, 7(11), pp. 647–56. Available at: https://doi.org/10.1038/nrendo.2011.108.

Meier, Christian and Kränzlin, Marius E (2011) ‘Calcium supplementation, osteoporosis and cardiovascular disease’, Swiss Medical Weekly, 141, p. w13260. Available at: https://doi.org/10.4414/smw.2011.13260.

Meier C and Kraenzlin ME (2011) ‘Antiepileptics and bone health’, Therapeutic Advances in Musculoskeletal Disease, 3(5), pp. 235–243. Available at: https://doi.org/10.1177/1759720X11410769.

Meyer, U. et al. (2011) ‘Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial’, Bone, 48(4), pp. 792–7. Available at: https://doi.org/10.1016/j.bone.2010.11.018.

Rizzoli, R et al. (2011) ‘Indications to teriparatide treatment in patients with osteoporosis’, Swiss medical weekly, 141, p. w13297. Available at: https://doi.org/10.4414/smw.2011.13297.

Rohrbach, Marianne et al. (2011) ‘Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) : clinical, molecular and biochemical delineation’, Orphanet journal of rare diseases : OJRD, 6, p. 46. Available at: https://doi.org/10.1186/1750-1172-6-46.

Bodmer, Michael et al. (2010) ‘Proton pump inhibitors and fracture risk: true effect or residual confounding?’, Drug safety, 33(10), pp. 843–52. Available at: https://doi.org/10.2165/11536780-000000000-00000.

Bodmer, Michael et al. (2010) ‘Long-term metformin use is associated with decreased risk of breast cancer’, Diabetes care, 33(6), pp. 1304–8. Available at: https://doi.org/10.2337/dc09-1791.

Keel, Christina et al. (2010) ‘Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice’, Journal of Bone and Mineral Metabolism, 28(1), pp. 68–76. Available at: https://doi.org/10.1007/s00774-009-0101-7.

Kraenzlin, Marius E et al. (2010) ‘Possible beneficial effect of bisphosphonates in osteonecrosis of the knee’, Knee surgery, sports traumatology, arthroscopy, 18(12), pp. 1638–44. Available at: https://doi.org/10.1007/s00167-010-1106-4.

Meier, Christian et al. (2010) ‘Use of depot medroxyprogesterone acetate and fracture risk’, Journal of clinical endocrinology and metabolism, 95(11), pp. 4909–16. Available at: https://doi.org/10.1210/jc.2010-0032.

Walter, Martin A. et al. (2010) ‘Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer’, Cancer, 116(1), pp. 31–40. Available at: https://doi.org/10.1002/cncr.24738.

Richert L et al. (2009) ‘Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy’, Swiss Medical Weekly, 139(27-28), pp. 400–404. Available at: https://doi.org/10.4414/smw.2009.12635.

Meier C et al. (2009) ‘[Thiazolidinediones and skeletal health].’, Revue medicale suisse, 5(207), pp. 1309–10, 1312–3.

Bodmer, Michael et al. (2009) ‘Risk of fractures with glitazones : a critical review of the evidence to date’, Drug safety, pp. 539–47. Available at: https://doi.org/10.2165/00002018-200932070-00001.

De Geyter, C. et al. (2009) ‘Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls’, Thyroid, 19(1), pp. 53–9. Available at: https://doi.org/10.1089/thy.2007.0355.

Hollaender, R et al. (2009) ‘Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: results of the Basel Osteoporosis Study’, Annals of the rheumatic diseases : ARD, 68(3), pp. 391–6. Available at: https://doi.org/10.1136/ard.2007.083618.

Meier, Christian (2009) ‘[Osteoporosis: diagnostic assessment]’, Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine PRAXIS, 98(20), pp. 1141–7. Available at: https://doi.org/10.1024/1661-8157.98.20.1141.

Meier, Christian, Seibel, Markus J and Kraenzlin, Marius E (2009) ‘Use of bone turnover markers in the real world: are we there yet?’, Journal of bone and mineral research : JBMR : the official journal of the American Society for Bone and Mineral Research, 24(3), pp. 386–8. Available at: https://doi.org/10.1359/jbmr.090104.

Kraenzlin ME, Anliker M and Griesmacher A (2008) ‘[Laboratory assessment of osteoporosis].’, Therapeutische Umschau. Revue therapeutique, 65(9), pp. 513–8. Available at: https://doi.org/10.1024/0040-5930.65.9.513.

Bodmer, Michael et al. (2008) ‘Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis’, Diabetes Care, 31(11), pp. 2086–91. Available at: https://doi.org/10.2337/dc08-1171.

Fukada, Toshiyuki et al. (2008) ‘The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways’, PloS one, 3(11), p. e3642. Available at: https://doi.org/10.1371/journal.pone.0003642.

Kraenzlin, Marius E. et al. (2008) ‘Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases’, Clinical chemistry, 54(9), pp. 1546–53. Available at: https://doi.org/10.1373/clinchem.2008.105262.

Meier, Christian et al. (2008) ‘Use of thiazolidinediones and fracture risk’, Archives of internal medicine, 168(8), pp. 820–825. Available at: https://doi.org/10.1001/archinte.168.8.820.

Meier, Christian et al. (2008) ‘Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study’, Archives of internal medicine, 168(1), pp. 47–54. Available at: https://doi.org/10.1001/archinternmed.2007.2.

Kränzlin,ME and Meier,C (2008) ‘Prävention der Osteoporose’, Ars Medici, 13(5), pp. 581–585.

Meier,C and Kränzlin,ME (2008) ‘Aromatasehemmer und Osteoporose’, Leading Opinons Gynäkologie, 1(4), pp. 14–17.